loading page

The Evaluation of Flow Mediated Dilatation and Blood Parameters in Raynaud Phenomenon
  • Suheyla UZUN,
  • Ilker KAYA
Suheyla UZUN
Tokat Gaziosmanpa┼ča University

Corresponding Author:[email protected]

Author Profile
Ilker KAYA
Tokat State Hospital
Author Profile


Introduction: Raynaud phenomenon (RP) is a multifactorial disorder. If any underlying disease cannot be detected responsible for RP then it considered as primary RP (pRP). We aimed to investigate the differences between laboratory markers and impaired endothelial function in pRP. Material and Methods: Forty-two pRP patients included as study and control groups were created from 30 healthy individuals. The endothelial function was evaluated with flow-mediated dilatation (FMD) of the brachial artery. The blood samples were obtained both groups and white blood cell [WBC], hemoglobin, platelet, mean platelet volume [MPV], creatinine, alanine aminotransferase [ALT], aspartate aminotransferase[AST], D-dimer, fibrinogen, albumin, fibrinogen to albumin ratio [FAR], Neutrophil to Lymphocyte ratio [NLR], D-dimer to albumin ratio [DDAR] and monocyte chemo-attractant protein-1 [MCP-1]. Obtained blood parameters and FMD values were compared between groups. Results: The groups were found as similar in regards to age, gender, smoking history (p<0.05). There was no difference between the two groups in regards to hemoglobin, platelet, MPV, creatinine, ALT, D-dimer, albumin, FAR, NLR, DDAR levels (p<0.05). AST levels were slightly higher in pRP group (p=0.027). Markedly increased WBC, fibrinogen, MPV and MCP-1 values were detected in pRP group (p=0.000). Additionally, higher abnormal FMD responses were detected in pRP group (p=0.000). There was a direct correlation between abnormal FMD response and serum MCP-1 values in patients with pRP (R: 0.308, R2: 0.095, p: 0.044). Conclusion: It seems to be that MCP-1 levels are higher in patients with pRP and increased values of MCP-1 levels seem to be related to impaired endothelial functions
23 Jun 2021Submitted to International Journal of Clinical Practice
24 Jun 2021Submission Checks Completed
24 Jun 2021Assigned to Editor
05 Aug 2021Reviewer(s) Assigned
22 Aug 2021Review(s) Completed, Editorial Evaluation Pending
30 Aug 2021Editorial Decision: Revise Major
02 Sep 20211st Revision Received
04 Sep 2021Submission Checks Completed
04 Sep 2021Assigned to Editor
04 Sep 2021Review(s) Completed, Editorial Evaluation Pending
10 Sep 2021Reviewer(s) Assigned
27 Sep 2021Editorial Decision: Revise Minor